FDA Adverse Event Injury Summary report: N

UNKNOWN HIP FEMORAL STEM

MDR report key: 9254663 · Received October 30, 2019

Report

Report Number
1818910-2019-113026
Event Type
Injury
Date Received
October 30, 2019
Date of Event
April 28, 2013
Report Date
October 7, 2019
Manufacturer
DEPUY ORTHOPAEDICS INC US
Product Code
KWA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

PRODUCT COMPLAINT # (B)(4). INVESTIGATION SUMMARY ==> NO DEVICE ASSOCIATED WITH THIS REPORT WAS RECEIVED FOR EXAMINATION. A WORLDWIDE LOT SPECIFIC COMPLAINT DATABASE SEARCH, OR DEVICE HISTORY RECORD (DHR) REVIEW WAS NOT POSSIBLE BECAUSE THE REQUIRED LOT CODE(S) WAS NOT PROVIDED. THE INFORMATION RECEIVED WILL BE RETAINED FOR POTENTIAL SERIES INVESTIGATIONS IF TRIGGERED BY TREND ANALYSIS, POST MARKET SURVEILLANCE, OR OTHER EVENTS WITHIN THE QUALITY SYSTEM. CORRECTIVE ACTION WAS NOT INDICATED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

(B)(4). IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. (B)(4).

Description of Event or Problem · 1

THE LITERATURE ARTICLE ENTITLED, ""RETAINING WELL-FIXED CEMENTLESS STEM IN THE TREATMENT OF INFECTED HIP ARTHROPLASTY"" WRITTEN BY YOUNG-KYUN LEE, KEE HAENG LEE, JAE-HWI NHO, YONG-CHAN HA & KYUNG-HOI KOO PUBLISHED BY ACTA ORTHOPAEDICA 2013; 84 (3): 260¿264 PUBLISHED ONLINE 28 APRIL 2013 WAS REVIEWED. THE ARTICLE'S PURPOSE WAS TO DETERMINE WHETHER INFECTION AFTER HIP ARTHROPLASTY CAN BE TREATED WITHOUT REMOVAL OF A WELL FIXED STEM. DATA WAS COMPILED FROM 19 PATIENTS IN 3 HOSPITALS (7 MEN AND 12 WOMEN, 19 HIPS RECEIVING A 2 STAGE REVISION TREATMENT FOR INFECTION FROM JANUARY 2005 TO APRIL 2010. IT IS NOTED THAT A TABLE ON PAGE 261 PROVIDES A LIST OF ALL PATIENTS WITH IDENTIFIERS AND IDENTIFIED PRODUCTS. EACH PATIENT WITH DEPUY PRODUCTS IS CAPTURED INDIVIDUALLY ON LINKED COMPLAINTS. ALL PATIENTS HAD ALL IMPLANTS EXPLANTED THEN RECEIVED AN ANTIBIOTIC IMPREGNATED SPACER FOR A VARIED DURATION OF TIME WITH BONE GRAFTING IF NECESSARY AND THEN FINAL STAGE OF NEW IMPLANTS THAT ARE NOT IDENTIFIED. THIS COMPLAINT CAPTURES CASE 14 A MALE (B)(6) WITH INITIAL SUMMIT STEM THAT RECEIVED NO IRRIGATION AND DEBRIDEMENT FOR INFECTION 9 MONTHS POST INITIAL IMPLANTATION FOLLOWED BY SPACER IMPLANTATION DURATION OF 2 MONTHS BEFORE RECEIVING NEW UNIDENTIFIED IMPLANTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1050674 UNKNOWN HIP FEMORAL STEM HIP FEMORAL STEM KWA DEPUY ORTHOPAEDICS INC US

Patients

Seq Age Sex Outcome Treatment
1 85 YR Required Intervention